{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:52:06Z","timestamp":1792738326799,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,2]],"date-time":"2027-06-02T00:00:00Z","timestamp":1811894400000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.contraception.2025.110943","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T12:48:12Z","timestamp":1746794892000},"page":"110943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Thrombosis risk with the use of hormonal contraception among women with thrombophilia: An updated systematic review"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2213-6382","authenticated-orcid":false,"given":"Naomi K.","family":"Tepper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Baumhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Schieve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura K.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2025.110943_bib1","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/AOG.0000000000000411","article-title":"Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes","volume":"124","author":"Bergendal","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110943_bib2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1055\/s-0037-1616136","article-title":"Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism","volume":"86","author":"Emmerich","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2025.110943_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/bjh.16666","article-title":"The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk","volume":"191","author":"Khialani","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2025.110943_bib4","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2008-06-160135","article-title":"Effect of elevated levels of coagulation factors on the risk of venous thrombosis in long-distance travelers","volume":"113","author":"Kuipers","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2025.110943_bib5","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1053\/euhj.2001.3082","article-title":"Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use","volume":"23","author":"Legnani","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.contraception.2025.110943_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/01.ATV.19.3.700","article-title":"Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis","volume":"19","author":"Martinelli","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.contraception.2025.110943_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/13625180008500383","article-title":"Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?","volume":"5","author":"Spannagl","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2025.110943_bib8","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/jth.13045","article-title":"Hypercoagulability and the risk of myocardial infarction and ischemic stroke in young women","volume":"13","author":"Siegerink","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2025.110943_bib9","first-page":"844","article-title":"Oral contraceptive use, thrombophilia and their interaction in young women with ischemic stroke","volume":"91","author":"Martinelli","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.contraception.2025.110943_bib10","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/01.AOG.0000433981.36184.4e","article-title":"ACOG Practice Bulletin No. 138: inherited thrombophilias in pregnancy","volume":"122","author":"ACOG","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110943_bib11","article-title":"Combined oral contraceptives: venous thrombosis","volume":"2014","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2025.110943_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00993","article-title":"Oral contraceptive use and increased risk of stroke: a dose-response meta-analysis of observational studies","volume":"10","author":"Li","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.contraception.2025.110943_bib13","article-title":"Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke","volume":"2015","author":"Roach","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2025.110943_bib14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.contraception.2016.10.005","article-title":"Nonoral combined hormonal contraceptives and thromboembolism: a systematic review","volume":"95","author":"Tepper","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110943_bib15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/AOG.0000000000004896","article-title":"Association of progestogens and venous thromboembolism among women of reproductive age","volume":"140","author":"Cockrum","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110943_bib16","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/2047487318774847","article-title":"Association between progestin-only contraceptive use and cardiometabolic outcomes: a systematic review and meta-analysis","volume":"25","author":"Glisic","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.contraception.2025.110943_bib17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110943_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2025.110943_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.contraception.2005.08.011","article-title":"Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review","volume":"73","author":"Mohllajee","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110943_bib20","unstructured":"Nguyen A., Curtis K., Tepper N., Hooper C. Safety of hormonal contraception among women with thrombophilias: a systematic review: PROSPERO 2019. Available from: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42019127163."},{"key":"10.1016\/j.contraception.2025.110943_bib21","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2025.110943_bib22","unstructured":"Veritas Health Innovation. Covidence systematic review software. \u3008https:\/\/www.covidence.org\/\u3009 (accessed December 13, 2024)."},{"key":"10.1016\/j.contraception.2025.110943_bib23","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022)","article-title":"Chapter 25: Assessing risk of bias in a non-randomized study","author":"Sterne","year":"2022"},{"key":"10.1016\/j.contraception.2025.110943_bib24","unstructured":"GRADEpro Guideline Development Tool [Software]. 2022. Hamilton (ON): McMaster University (developed by Evidence Prime). \u3008https:\/\/www.gradepro.org\/\u3009."},{"key":"10.1016\/j.contraception.2025.110943_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.contraception.2025.110943_bib26","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2025.110943_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-0037-1614213","article-title":"Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism","volume":"79","author":"Andersen","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2025.110943_bib28","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJM199806183382502","article-title":"High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives","volume":"338","author":"Martinelli","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2025.110943_bib29","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2025.110943_bib30","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1182\/blood-2003-02-0443","article-title":"Hyperhomocysteinemia in cerebral vein thrombosis","volume":"102","author":"Martinelli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2025.110943_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2147\/JBM.S212759","article-title":"Clinical and laboratory manifestations of the prothrombin gene mutation in women of reproductive age","volume":"10","author":"Momot","year":"2019","journal-title":"J Blood Med"},{"key":"10.1016\/j.contraception.2025.110943_bib32","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1055\/s-0038-1642480","article-title":"Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication","volume":"71","author":"Pabinger","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2025.110943_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2004.02.010","article-title":"Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives","volume":"70","author":"Sidney","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110943_bib34","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1538-7836.2005.01442.x","article-title":"Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke","volume":"3","author":"Slooter","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2025.110943_bib35","first-page":"s337","article-title":"Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis","volume":"12 1","author":"Tufano","year":"2014","journal-title":"Blood Transfus"},{"key":"10.1016\/j.contraception.2025.110943_bib36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archinte.167.3.282","article-title":"Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study","volume":"167","author":"van Vlijmen","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.contraception.2025.110943_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.160.1.49","article-title":"Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects","volume":"160","author":"Bloemenkamp","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.contraception.2025.110943_bib38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bmj.316.7131.589","article-title":"Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users who are carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group","volume":"316","author":"de Bruijn","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2025.110943_bib39","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2025.110943_bib40","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7326\/0003-4819-135-5-200109040-00008","article-title":"A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism","volume":"135","author":"Middeldorp","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.contraception.2025.110943_bib41","first-page":"965","article-title":"Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene","volume":"86","author":"Santamaria","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.contraception.2025.110943_bib42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1055\/s-0037-1613373","article-title":"Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk","volume":"89","author":"Vaya","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2025.110943_bib43","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.thromres.2012.05.024","article-title":"Risk factors for venous thromboembolism in pre-and postmenopausal women","volume":"130","author":"Bergendal","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.contraception.2025.110943_bib44","unstructured":"CDC. Supplementary Appendix. U.S. medical eligibility criteria for contraceptive use, 2024. 2024. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/156516 (accessed December 13, 2024)."},{"key":"10.1016\/j.contraception.2025.110943_bib45","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(09)70239-X","article-title":"Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study","volume":"8","author":"Urbanus","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.contraception.2025.110943_bib46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ccm.2010.07.004","article-title":"Hypercoagulable states","volume":"31","author":"Anderson","year":"2010","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.contraception.2025.110943_bib47","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1160\/TH15-02-0141","article-title":"Classic thrombophilic gene variants","volume":"114","author":"Mannucci","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2025.110943_bib48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/jth.15082","article-title":"Antiphospholipid syndrome: complement activation, complement gene mutations, and therapeutic implications","volume":"19","author":"Chaturvedi","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2025.110943_bib49","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.fertnstert.2016.08.039","article-title":"Hormonal contraception and thrombosis","volume":"106","author":"Sitruk-Ware","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2025.110943_bib50","article-title":"Impact of progestogens on hemostasis","volume":"37","author":"Skouby","year":"2018","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/j.contraception.2025.110943_bib51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/13625180600772741","article-title":"Metabolic and clinical effects of progestogens","volume":"11","author":"Wiegratz","year":"2006","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2025.110943_bib52","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 Guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425001349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425001349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T02:18:10Z","timestamp":1780712290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782425001349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":52,"alternative-id":["S0010782425001349"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2025.110943","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombosis risk with the use of hormonal contraception among women with thrombophilia: An updated systematic review","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2025.110943","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110943"}}